Showing 3961-3970 of 19385 results for "".
Recognizing Neonatal FPIES: Key Clues for Early Diagnosis and Treatment
https://reachmd.com/programs/clinicians-roundtable/recognizing-neonatal-fpies-key-clues-for-early-diagnosis-and-treatment/37132/Neonatal food protein-induced enterocolitis syndrome (N-FPIES) is an underrecognized condition often misdiagnosed as necrotizing enterocolitis, despite distinct clinical and lab features that demand a different treatment approach. In this AudioAbstract, ReachMD's Ryan Quigley explores the earPsoriasis Care: Exploring Advancements in Biologics and Topicals
https://reachmd.com/programs/frontlines-psoriasis/psoriasis-care-exploring-advancements-in-biologics-and-topicals/32451/Learn how advancements in biologics and topicals have improved psoriasis care and what considerations are influencing future treatment development.Research Highlights Disparities in AD Care
https://reachmd.com/programs/practical-dermatology/research-highlights-disparities-in-ad-care/36472/In this episode of DermwireTV, research on socioeconomic disparities in atopic dermatitis care; new information on guselkumab for scalp psoriasis in diverse skin tones; the impact of air quality on dermatitis; and a C-Suite Chat with Anastasia Georgievskaya, founder of Haut.AI.Understanding Extensive-Stage Small Cell Lung Cancer: Advancements and Ongoing Challenges
https://reachmd.com/programs/deep-breaths-updates-chest/understanding-extensive-stage-small-cell-lung-cancer-advancements-and-ongoing-challenges/32973/Despite the typically poor prognosis of extensive-stage small cell lung cancer, recent advancements are reshaping clinical perspectives on treatment. New and emerging options show promise for prolonged survival and improved quality of life. Join Drs. Gerard Silvestri, Adam Fox, Mariam Alexander, andDebunking gMG Myths: Counseling Strategies That Change the Conversation
https://reachmd.com/programs/neurofrontiers/debunking-gmg-myths-counseling-strategies-that-change-the-conversation/35494/Misconceptions about disease progression and exercise are common among patients with generalized myasthenia gravis (gMG), especially early in their diagnosis. This underscores the importance of using relatable analogies and simplified explanations to help patients better understand their disease soEvolving Strategies in Lupus Care: Recent Findings and Ongoing Challenges
https://reachmd.com/programs/living-rheum/evolving-strategies-in-lupus-care-recent-findings-and-ongoing-challenges/32793/Our approach to lupus management is accelerating, with emerging results on targeted therapies in skin and renal disease showing promise. Dr. Michelle Kahlenberg shares insights on emerging biologics, CAR-T innovations, and potential barriers in translating treatment breakthroughs into real-world patSlowing Prostate Cancer Progression: The Role of Dietary Fat Modifications
https://reachmd.com/programs/frontlines-prostate-cancer/slowing-prostate-cancer-progression-the-role-of-dietary-fat-modifications/32209/Altering dietary fat intake may help slow the progression of prostate cancer. Here’s what a recent study found on this connection.Rheumatoid Arthritis Care: Examining the Current Landscape and Emerging Research
https://reachmd.com/programs/living-rheum/rheumatoid-arthritis-care-examining-the-current-landscape-and-emerging-research/18108/Hear expert insights on rheumatoid arthritis treatment, from evolving drug options to safer approaches for patients with difficult-to-treat cases.Safety Outcomes in MS Clinical Trials: Examining Comorbidities and Adverse Events
https://reachmd.com/programs/neurofrontiers/safety-outcomes-in-ms-clinical-trials-examining-comorbidities-and-adverse-events/32705/Learn how comorbidities are related to adverse events and early discontinuation in phase III multiple sclerosis trials.ATTR Peripheral Neuropathy: How to Avoid Misdiagnosis
https://reachmd.com/programs/neurofrontiers/tbd/26390/Tune in to find out how we can distinguish transthyretin amyloid polyneuropathy from other neuropathies to improve patient outcomes.